Supplementary Table 3.
Newcastle-Ottawa scale domains |
Total | |||
---|---|---|---|---|
Selection | Comparability | Outcome | ||
DS meta-analysis | ||||
Beshara et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Corley et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Flugelman et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Kaalby et al | ||||
Items | 1A, 2C, 3A, 4A | 1AB | 1B, 2B, 3A | |
Point | 3 | 2 | 2 | 7 |
Kim et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 2 | 2 | 3 | 7 |
Lee et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Rutter et al | ||||
Items | 1C, 2C, 3A, 4A | 1B, 2A, 3A | ||
Point | 2 | 0 | 3 | 5 |
Zorzi et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
SM meta-analysis | ||||
Brouwer et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Chiang et al | ||||
Items | 1B, 2A, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 4 | 2 | 3 | 9 |
Gunderson et al | ||||
Items | 1C, 2C, 3A, 4A | 1A | 1B,2A,3C | |
Point | 2 | 1 | 2 | 5 |
Innos et al | ||||
Items | 1C, 2C, 3A, 4A | 1A | 1B, 2A, 3A | |
Point | 2 | 1 | 3 | 6 |
Li et al | ||||
Items | 1A, 2A, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 4 | 2 | 3 | 9 |
Minicozzi et al | ||||
Items | 1B, 2C, 3A, 4A | 1A | 1B, 2A, 3A | |
Point | 3 | 1 | 3 | 7 |
Odgaard et al | ||||
Items | 1A, 2C, 3A, 4A | 1A | 1B, 2A, 3A | |
Point | 3 | 1 | 3 | 7 |
Rutter et al | ||||
Items | 1A, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
Wang et al | ||||
Items | 1A, 2A, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 4 | 2 | 3 | 9 |
Zhang et al | ||||
Items | 1B, 2C, 3A, 4A | 1AB | 1B, 2A, 3A | |
Point | 3 | 2 | 3 | 8 |
NOTE. Scale range is 0–9.
DS, delay stage; SM, stage mortality.